Utilisation of anti-TNF levels in a UK tertiary IBD centre.

about

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

Item

http://www.wikidata.org/entity/Q38608944

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

@en

type

Item

label

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

@en

prefLabel

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

@en

P1476

Utilisation of anti-TNF levels in a UK tertiary IBD centre

@en

P2093

B D Warner

http://www.w3.org/2001/XMLSchema#string

J D Sanderson

http://www.w3.org/2001/XMLSchema#string

J L Digby-Bell

http://www.w3.org/2001/XMLSchema#string

N Unsworth

http://www.w3.org/2001/XMLSchema#string

P M Irving

http://www.w3.org/2001/XMLSchema#string

S Anderson

http://www.w3.org/2001/XMLSchema#string

Z Arkir

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Infliximab maintenance therapy for fistulizing Crohn's disease

Infliximab for induction and maintenance therapy for ulcerative colitis

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.

Review article: loss of response to anti-TNF treatments in Crohn's disease.

Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease.

Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease.

P304

189-195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/FLGASTRO-2016-100739

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emma Johnston

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28839908

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor

P932

5558278

http://www.w3.org/2001/XMLSchema#string